Theralase Technologies Inc. (TLTFF)
USD 0.19
(4.11%)
USD 0.19
(4.11%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 293.86 Thousand CAD | -24.04% |
| 2022 | 386.87 Thousand CAD | 0.0% |
| 2021 | - CAD | -100.0% |
| 2020 | 35.72 Thousand CAD | -62.19% |
| 2019 | 94.47 Thousand CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | -100.0% |
| 2013 | 163.00 CAD | -79.08% |
| 2012 | 779.00 CAD | -45.71% |
| 2011 | 1435.00 CAD | -95.1% |
| 2010 | 29.28 Thousand CAD | -38.61% |
| 2009 | 47.7 Thousand CAD | 117.69% |
| 2008 | 21.91 Thousand CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| 2004 | - CAD | 0.0% |
| 2003 | - CAD | 0.0% |
| 2002 | - CAD | 0.0% |
| 2001 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 244.86 Thousand CAD | 0.0% |
| 2024 Q1 | 269.58 Thousand CAD | 0.0% |
| 2023 Q4 | 293.86 Thousand CAD | -7.51% |
| 2023 FY | 293.86 Thousand CAD | -24.04% |
| 2023 Q2 | 364.23 Thousand CAD | 0.0% |
| 2023 Q3 | 317.73 Thousand CAD | -12.77% |
| 2023 Q1 | 364.23 Thousand CAD | -5.85% |
| 2022 FY | 386.87 Thousand CAD | 0.0% |
| 2022 Q4 | 386.87 Thousand CAD | -4.22% |
| 2022 Q3 | 403.92 Thousand CAD | -5.04% |
| 2022 Q1 | - CAD | 0.0% |
| 2022 Q2 | 425.35 Thousand CAD | 0.0% |
| 2021 Q4 | - CAD | 0.0% |
| 2021 FY | - CAD | -100.0% |
| 2021 Q1 | 20.84 Thousand CAD | -41.64% |
| 2021 Q2 | 5675.00 CAD | -72.78% |
| 2021 Q3 | - CAD | -100.0% |
| 2020 Q1 | 75.32 Thousand CAD | -20.27% |
| 2020 Q2 | 64.59 Thousand CAD | -14.24% |
| 2020 FY | 35.72 Thousand CAD | -62.19% |
| 2020 Q4 | 35.72 Thousand CAD | -30.5% |
| 2020 Q3 | 51.4 Thousand CAD | -20.43% |
| 2019 Q2 | 109.01 Thousand CAD | 0.0% |
| 2019 Q3 | 97.39 Thousand CAD | -10.66% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 Q4 | 94.47 Thousand CAD | -3.0% |
| 2019 FY | 94.47 Thousand CAD | 0.0% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q1 | - CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2014 FY | - CAD | -100.0% |
| 2014 Q4 | - CAD | -100.0% |
| 2014 Q3 | 42.00 CAD | 0.0% |
| 2014 Q2 | 42.00 CAD | 0.0% |
| 2014 Q1 | 42.00 CAD | -74.23% |
| 2013 FY | 163.00 CAD | -79.08% |
| 2013 Q4 | 163.00 CAD | -41.37% |
| 2013 Q2 | 388.00 CAD | -34.13% |
| 2013 Q1 | 589.00 CAD | -24.39% |
| 2013 Q3 | 278.00 CAD | -28.35% |
| 2012 Q2 | 1126.00 CAD | -12.37% |
| 2012 Q1 | 1285.00 CAD | -10.45% |
| 2012 FY | 779.00 CAD | -45.71% |
| 2012 Q3 | 957.00 CAD | -15.01% |
| 2012 Q4 | 779.00 CAD | -18.6% |
| 2011 FY | 1435.00 CAD | -95.1% |
| 2011 Q1 | 5764.00 CAD | -80.32% |
| 2011 Q2 | 5764.00 CAD | 0.0% |
| 2011 Q4 | 1435.00 CAD | -75.1% |
| 2011 Q3 | 5764.00 CAD | 0.0% |
| 2010 Q2 | 43.28 Thousand CAD | -4.15% |
| 2010 FY | 29.28 Thousand CAD | -38.61% |
| 2010 Q4 | 29.28 Thousand CAD | -27.97% |
| 2010 Q1 | 45.15 Thousand CAD | -5.34% |
| 2010 Q3 | 40.66 Thousand CAD | -6.06% |
| 2009 FY | 47.7 Thousand CAD | 117.69% |
| 2009 Q1 | 21.91 Thousand CAD | 0.0% |
| 2009 Q2 | 15.27 Thousand CAD | -30.29% |
| 2009 Q3 | 58 Thousand CAD | 279.66% |
| 2009 Q4 | 47.7 Thousand CAD | -17.75% |
| 2008 Q1 | - CAD | 0.0% |
| 2008 FY | 21.91 Thousand CAD | 0.0% |
| 2008 Q4 | 21.91 Thousand CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q4 | - CAD | 0.0% |
| 2007 Q3 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| 2005 Q1 | - CAD | 0.0% |
| 2005 Q2 | - CAD | 0.0% |
| 2005 Q3 | - CAD | 0.0% |
| 2005 Q4 | - CAD | 0.0% |
| 2004 Q4 | - CAD | 0.0% |
| 2004 Q3 | - CAD | 0.0% |
| 2004 Q1 | - CAD | 0.0% |
| 2004 FY | - CAD | 0.0% |
| 2004 Q2 | - CAD | 0.0% |
| 2003 Q3 | - CAD | 0.0% |
| 2003 Q4 | - CAD | 0.0% |
| 2003 Q2 | - CAD | 0.0% |
| 2003 Q1 | - CAD | 0.0% |
| 2003 FY | - CAD | 0.0% |
| 2002 Q4 | - CAD | 0.0% |
| 2002 FY | - CAD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2001 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | 34.621% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 99.906% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | 98.442% |
| Össur hf. | 311.8 Million USD | 99.906% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | -5.176% |
| Aurora Spine Corporation | 1.59 Million USD | 81.539% |
| BrainsWay Ltd. | 239 Thousand USD | -22.957% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | 97.655% |
| Hamilton Thorne Ltd. | 16.7 Million USD | 98.241% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -35.042% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -572.834% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.89 Million USD | 92.458% |
| Nanomix Corporation | 10.11 Million USD | 97.094% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | 52.449% |
| Theraclion SA | 1.95 Million EUR | 84.936% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -95.911% |
| Lombard Medical, Inc. | 28.02 Million USD | 98.951% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 99.671% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -20.79% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 99.964% |
| VMS Rehab Systems, Inc. | 106.45 USD | -275961.062% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 511 Thousand USD | 42.492% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | 44.79% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | 50.192% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | 3.524% |
| SANUWAVE Health, Inc. | 492 Thousand USD | 40.271% |
| IR-Med Inc. | 161 Thousand USD | -82.526% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -106.47% |
| Polarean Imaging plc | 74.84 Thousand USD | -292.629% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | 63.449% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | 8.851% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -153.216% |
| Urologix, Inc. | 4.58 Million USD | 93.592% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | 31.696% |
| Nexeon MedSystems Inc. | 2.78 Million USD | 89.453% |
| SS Innovations International, Inc. | 1.91 Million USD | 84.618% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.986% |
| NIOX Group Plc | 500 Thousand USD | 41.227% |
| Fuse Medical, Inc. | 200 Thousand USD | -46.934% |
| Broncus Holding Corporation | 1.22 Million USD | 75.991% |
| Brain Scientific Inc. | 7378.00 USD | -3883.017% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -81.552% |
| Health Logic Interactive Inc. | - USD | -Infinity% |